Fundz

Ibex Raises $55 Million In Series C Funding To Drive Global Adoption Of Ai For Cancer Diagnosis

PRIVATESep 06, 2023

Amount Raised

$55 Million

Round Type

Series C

Tel AvivInformation TechnologyBiotechnologySoftwareHealth CareArtificial IntelligenceMachine LearningHealth Diagnostics

Investors

Dell Technologies CapitalPlanven Entrepreneur VenturesA MoonOctopus VenturesSienna Venture Capital83 North

Description

Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100 million since Ibex's inception in 2016.

Company Information

Company

Ibex Medical Analytics

Location

Tel Aviv, Tel Aviv District, Israel

About

Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity. We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Our Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Galen is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: transform cancer diagnosis with AI and improve patient care. If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to make real impact – we want to hear from you.

Fundz sees it the moment Ibex Medical Analytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJoseph (Yossi) M., Co-Founder & CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ibex Medical Analytics's next move

See what Strategic adds

Ibex Medical Analytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.